Nav: Home

Study finds adaptive IGRT for bladder preservation clinically feasible

March 29, 2016

Fairfax, Va., March 29, 2016 - A prospective study examining a trimodality treatment approach in localized bladder cancer cases using adaptive image-guided, intensity-modulated radiation therapy (IG-IMRT) found that the bladder preservation rate at three years was 83 percent.

Approximately 150,000 people worldwide die every year as a result of urinary bladder cancer. Patients with moderately advanced bladder cancer typically undergo surgery with removal of the bladder resulting in the use of an external urine bag. The trimodality plan, which consists of the transurethral resection of the bladder tumor (TURBT), IG-IMRT and chemotherapy, was developed as a bladder conservation protocol to preserve bladder function with good oncological outcomes.

"Adaptive IGRT [with] plan-of-the-day approach for bladder preservation is clinically feasible, with good oncological outcomes and low rates of acute and late toxicities. Dose escalation is safe and possibly improves outcomes in bladder preservation," said Vedang Murthy, MD, radiation oncology, Tata Memorial Centre, Mumbai, India and lead author of the study, "Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study," published in the International Journal of Radiation Oncology * Biology * Physics (Red Journal).

"With adaptive IGRT, increasing the dose becomes possible, and serious side effects may be kept low, ensuring a good quality of life for our patients," Dr. Murthy said.

The study looked at 44 patients between August 2008 and August 2014. Thirty nine (88 percent) patients were male and five (11 percent) were female, ranging in ages from 55 to 72. Eighty-eight percent of patients had stage 2 disease. Patients underwent maximal safe resection of bladder tumor and concurrent platinum-based chemotherapy, and those with large tumors were offered induction chemotherapy.

RT planning was done using either three (n=34) or six (n=10) non-concentrically grown planning target volumes (PTV). Patients received 64 Gy in 32 fractions to the whole bladder and 55 Gy to the pelvic nodes. If appropriate, they received a simultaneous integrated boost to the tumor bed to 68 Gy. Daily megavoltage imaging was used to find the most appropriate PTV encompassing bladder for the particular day with the plan-of-the-day approach.

At six to ten weeks post-treatment, all patients had a complete response. The study had a median follow-up of 30 months. Overall survival at the last follow up was 77 percent (34 patients). Among those who died, three died from comorbidities and were disease free at the time of death.

The three-year locoregional control (LRC), disease-free survival and overall survival (OS) rates were 78 percent, 66 percent and 67 percent, respectively. Rates of LRC and OS were better in patients who received dose escalation. Acute and late Radiation Therapy Oncology Group (RTOG) grade 3 genitourinary toxicity was seen in five (11 percent) and two (four percent) patients, respectively. No acute or late RTOG grade 3 or higher gastrointestinal toxicity occurred.

"Adaptive RT (ART) further helps in reduction of doses to normal tissues and improves accuracy of delivery," Dr. Murthy said. "These procedures, in theory, should result in less acute and late toxicity, while allowing for dose escalation to gross tumor to improve outcomes."

"Although a number of investigators have conceived and developed a variety of ART techniques, there are few clinical outcome data to validate this dosimetric concept. The present proof-of-concept prospective study was conducted with the aim of establishing the safety, ef?cacy, and feasibility of IG-IMRT-based ART in clinical practice," he said.

More follow-up with larger groups of patients is needed to establish the novel technique as the standard, Dr. Murthy said, but results from the study have shown the possibilities of ART in bladder cancer patients.

"These results provide proof of concept of using adaptive IGRT in the clinic," Dr. Murthy said. "This will hopefully lead to more and more suitable patients undergoing bladder preservation around the world."
-end-
For more information, contact ASTRO's Press Office at press@astro.org. For the study abstract, visit http://www.redjournal.org/article/S0360-3016(15)03321-0/abstract. For more information about the Red Journal, visit http://www.redjournal.org.

ABOUT ASTRO

ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology * Biology * Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers; and created the Radiation Oncology Institute, a nonprofit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit http://www.astro.org.

American Society for Radiation Oncology

Related Radiation Oncology Articles:

Poor methodology reporting makes radiation oncology studies impossible to replicate
Nearly 80 percent of radiation oncology studies funded by the National Institutes of Health involve investigating the effects that radiation has on tumor cells and healthy tissue in pre-clinical settings, such as experiments done in cell cultures or mice.
Radiation oncology workforce study indicates potential threat to rural cancer care access
The newest study of America's radiation oncology workforce finds that gender and race gaps have narrowed slightly, although persistent and growing geographic disparities point to a need for more equity in access to radiation therapy care.
Precision oncology insights revealed for colorectal cancer
Findings published in the Journal of Clinical Oncology could help define strategies to more effectively treat colorectal cancer, the second leading cause of cancer death in the United States.
Research on imaging in radiation oncology featured in Red Journal special issue
A new special edition of the International Journal of Radiation Oncology* Biology* Physics (Red Journal) focuses on the roles of imaging in radiation oncology.
Clinical trials, radiation oncology research to be featured at ASTRO's Annual Meeting
The American Society for Radiation Oncology (ASTRO) announced today the 10 top-rated studies that will be highlighted in the press program for the 2018 ASTRO Annual Meeting.
New material detects the amount of UV radiation and helps monitor radiation dose
Researchers at the University of Turku, Finland, have developed a synthetic SensoGlow™ material that detects the quantity and quality of ultraviolet radiation from the Sun or other sources.
Study finds medical students receive little formal instruction in radiation oncology
Medical school students receive little formal instruction in radiation oncology, a Loyola study has found.
Precision oncology in advanced cancer patients improves overall survival
Resource use intensity for patients in the targeted group was lower in both higher-cost, acute settings such as inpatient and ER as well in the lower acuity outpatient setting, compared to control patients.
New algorithm decodes spine oncology treatment
Experts explain their approach to treating patients who are living longer with cancer that has spread to the spine, as the options for metastatic spine tumors increase.
Cloudy with a chance of radiation: NASA studies simulated radiation
NASA's Human Research Program (HRP) is simulating space radiation on Earth following upgrades to the NASA Space Radiation Laboratory (NSRL) at the US Department of Energy's Brookhaven National Laboratory.
More Radiation Oncology News and Radiation Oncology Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab